{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:39:13Z","timestamp":1789540753889,"version":"build-2803163510"},"reference-count":52,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T00:00:00Z","timestamp":1370304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Euro Eating Disorders Rev"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>During the last 10\u2009years, the use of psychotropic medications in youth with psychiatric disorders, including eating disorders, has significantly increased, but their role in the treatment of adolescent anorexia nervosa is still controversial.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This paper aims to review the literature on the use of antidepressants and antipsychotics in adolescents with anorexia nervosa, comparing the efficacy and tolerability in this population with those reported in trials with patients not selected by age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A systematic review of the available literature published so far.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Only few studies met the selection criteria. No strong evidence of beneficial effects was found in using antidepressants and antipsychotics neither in adults nor in adolescents. Side effects were more frequently reported in studies including adolescent population.<\/jats:p><jats:p>Among psychotropic drugs, the majority of studies focused on olanzapine, which seems to have, in some studies, only positive effects on body mass index, eating disorder symptoms and functional impairment in both age groups. Copyright \u00a9 2013 John Wiley &amp; Sons, Ltd and Eating Disorders Association.<\/jats:p><\/jats:sec>","DOI":"10.1002\/erv.2240","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T11:11:06Z","timestamp":1370344266000},"page":"361-373","source":"Crossref","is-referenced-by-count":33,"title":["Psychotropic Drug Treatment in Anorexia Nervosa. Search for Differences in Efficacy\/Tolerability Between Adolescent and Mixed\u2010age Population"],"prefix":"10.1002","volume":"21","author":[{"given":"Matteo","family":"Balestrieri","sequence":"first","affiliation":[{"name":"Department of Psychiatry, DISM University of Udine  Udine Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ginevra","family":"Oriani","sequence":"additional","affiliation":[{"name":"Psychiatric Unit, United Hospitals of Ancona, DMH and Experimental and Clinical Medicine University Politecnica of Marche  Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Simoncini","sequence":"additional","affiliation":[{"name":"Psychiatric Unit, United Hospitals of Ancona, DMH and Experimental and Clinical Medicine University Politecnica of Marche  Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesario","family":"Bellantuono","sequence":"additional","affiliation":[{"name":"Psychiatric Unit, United Hospitals of Ancona, DMH and Experimental and Clinical Medicine University Politecnica of Marche  Ancona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10261"},{"key":"e_1_2_6_3_1","volume-title":"Diagnostic and statistical manual of mental disorders: DSM\u2010IV","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_6_4_1","unstructured":"Attia E.(2008).Olanzapine versus aripiprazole in adult anorexia nervosa. InProceedings of the 14thEDRS meeting Montreal September 2008."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.4.548"},{"key":"e_1_2_6_6_1","first-page":"1","article-title":"Olanzapine versus placebo for out\u2010patients with anorexia nervosa","volume":"22","author":"Attia E.","year":"2011","journal-title":"Psychological Medicine"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10235"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1106"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07121900"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.845"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328080ca31"},{"key":"e_1_2_6_12_1","unstructured":"Carver A. E. Millers S. Hagman J. &Siegel E.(2002).The use of risperidone for the treatment of anorexia nervosa. InProceedings of the Academy of Eating Disorders Annual Meeting Boston April 2002."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2010.03.011"},{"key":"e_1_2_6_14_1","first-page":"173","article-title":"A review of medication use for children and adolescents with eating disorders","volume":"16","author":"Couturier J.","year":"2007","journal-title":"Journal of the Canadian Academy of Child & Adolescent Psychiatry"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(02)00058-5"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.22037"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(06)70731-3"},{"key":"e_1_2_6_18_1","first-page":"1","article-title":"Does olanzapine affect the rate of weight gain among inpatients with eating disorders?","volume":"12","author":"Gaskill J. A.","year":"2001","journal-title":"Eating Disorders Review"},{"key":"e_1_2_6_19_1","first-page":"614","article-title":"Eating disorders in adolescents","volume":"36","author":"Gonzalez A.","year":"2007","journal-title":"Australian Family Physician"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-3588.2009.00535.x"},{"key":"e_1_2_6_21_1","first-page":"378","article-title":"Fluoxetine treatment of anorexia nervosa: An open clinical trial","volume":"51","author":"Gwirtsman H. E.","year":"1990","journal-title":"The Journal of Clinical Psychiatry"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2011.06.009"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2004.08.001"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0670-8"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0139"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)01013-1"},{"key":"e_1_2_6_27_1","first-page":"464","article-title":"An open trial of fluoxetine in patients with anorexia nervosa","volume":"52","author":"Kaye W. H.","year":"1991","journal-title":"The Journal of Clinical Psychiatry"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r07691"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1998.8.107"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm109"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(200004)27:3<363::AID-EAT16>3.0.CO;2-5"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0072"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-108X(199912)26:4<397::AID-EAT5>3.0.CO;2-0"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10122"},{"key":"e_1_2_6_35_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/j.1440-1665.2004.02154.x","article-title":"Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa","volume":"13","author":"Mondraty N.","year":"2005","journal-title":"Australasian Psychiatry"},{"key":"e_1_2_6_36_1","unstructured":"National Institute of Mental Health. (2010).www.clinicaltrials.gov[Last accessed 23 November 2011]"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/10640261003719468"},{"key":"e_1_2_6_38_1","first-page":"1","article-title":"Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa","volume":"20","author":"Norris M. L.","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03339979"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.20325"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/eat.10084"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.3.440"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922807303929"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00174-9"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(03)00029-0"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(88)90116-7"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454601750284045"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-8-4"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2008.07.013"},{"key":"e_1_2_6_50_1","first-page":"425","article-title":"Does adjunctive fluoxetine influence the post\u2010hospital course of restrictor\u2010type anorexia nervosa? A 24\u2010month prospective, longitudinal follow\u2010up and comparison with historical controls","volume":"33","author":"Strober M.","year":"1997","journal-title":"Psychopharmacological Bullettin"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1999.9.195"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.7.1073"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.22.2605"}],"container-title":["European Eating Disorders Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Ferv.2240","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/erv.2240","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T07:09:21Z","timestamp":1700636961000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/erv.2240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1002\/erv.2240"],"URL":"https:\/\/doi.org\/10.1002\/erv.2240","archive":["Portico"],"relation":{},"ISSN":["1072-4133","1099-0968"],"issn-type":[{"value":"1072-4133","type":"print"},{"value":"1099-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}